Makebot Advances Next-Generation Healthcare-Specialized Generative AI and LLM Platform

Three Patents Filed for Government-Validated Technology,
Proving the Competitiveness of Medical LLM Technology

Image provided by Freepik

AI specialist company Makebot (CEO Kim Jiwoong) announced that it has completed the advancement of its healthcare-specialized generative AI platform, based on technology validated through an R&D project by the Ministry of SMEs and Startups.

Makebot has already supplied AI consultation solutions to major medical institutions such as Seoul National University Hospital and Gangnam Severance Hospital. With this latest upgrade, the company has fully transformed its platform into a next-generation solution equipped with a large language model (LLM) specialized for the medical domain.

The core of the new platform is a healthcare-specialized LLM trained on medical terminology and patient interaction contexts. By leveraging actual consultation data from medical institutions and medical expertise accumulated through government R&D, the platform can accurately understand medical terms, the characteristics of each medical department, and hospital-specific processes-areas that are difficult for general LLMs to comprehend precisely.

In particular, by integrating the healthcare LLM with hospital system (EMR) APIs, patients can now handle a variety of tasks-such as making appointments, registration, receiving consultation guidance, and navigating hospital services-through a natural conversational flow. The platform can also understand and process complex queries like, "Is Professor Kim in the Department of Gastroenterology available for an appointment next Tuesday morning?" in a single step.

Makebot continues to drive ongoing innovative R&D in the healthcare sector based on a range of AI technologies-including deep learning, LLM, and HybridLLM-and the capabilities of its in-house research team, while maintaining close partnerships with major domestic and international hospitals and EMR providers.

Makebot validated its technology through the Ministry of SMEs and Startups' Startup Growth Technology Development (R&D) program, and during the development process, filed three additional patents related to generative AI-based chatbots. Furthermore, the company demonstrated its global technological prowess by presenting a paper on Retrieval-Augmented Generation (RAG) technology at SIGIR 2025, the world's most prestigious academic conference in the information retrieval field.

This next-generation platform offers real-time multilingual AI response capabilities, allowing international patients to receive consultations in their native languages. For hospital groups or franchise hospitals, the platform standardizes consultation quality across branches based on the healthcare LLM, delivering consistently high-quality services.

Kim Jiwoong, CEO of Makebot, stated, "By validating our technology through government R&D projects and securing patents, we have been able to complete a generative AI platform truly specialized for the medical domain." He emphasized, "We have achieved both accuracy and naturalness in patient interactions with AI trained specifically for healthcare."

He added, "With 24/7 consultation availability, zero waiting time, and multilingual support, healthcare LLM-based AI will dramatically improve access to medical services. We aim to grow as a medical AI platform company that also supports hospital operational efficiency through the analysis of accumulated consultation data."

Makebot plans to sequentially apply its advanced platform to major medical institutions and expand its healthcare-specialized generative AI solutions into the insurance, healthcare, and public medical sectors in the future.

This content was produced with the assistance of AI translation services.